Preformulation study of the inclusion complex warfarin-β-cyclodextrin

International Journal of Pharmaceutics

Volumn 291, Issue 1-2, 2005, Pages 3-10

  Zingone, G ^a   Rubessa, F ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Differential scanning calorimetry; Dissolution rate; Inclusion complex; Powder X ray diffractometry; Warfarin; Cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; UNCLASSIFIED DRUG; WARFARIN; WARFARIN BETA CYCLODEXTRIN;

CONFERENCE PAPER; DIFFERENTIAL SCANNING CALORIMETRY; DIFFRACTION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG FORMULARY; DRUG SOLUBILITY; DRUG SYNTHESIS; EVAPORATION; FREEZE DRYING; IONIZATION; PH MEASUREMENT; PHASE TRANSITION; PHYSICAL CHEMISTRY; PREFORMULATION; PRIORITY JOURNAL; ROOM TEMPERATURE; SOLID STATE; STATISTICAL SIGNIFICANCE; TECHNIQUE; THERMOGRAPHY;

EID: 13544258798     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.11.013     Document Type: Conference Paper

References (15)

1. H. Choi, D. Kim, H.W. Jun, B. Yoo, and C. Yong Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-β- cyclodextrin Drug Dev. Ind. Pharm. 29 2003 1085 1094
2. F. Damian, N. Blaton, L. Naesens, J. Balzarini, R. Kinget, P. Augustijns, and G. Van Der Mooter Physicochemical characterization of solid dispersion of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14 Eur. J. Pharm. Sci. 10 2000 311 322
3. C.M. Fernandes, M.T. Vieira, and F.J.B. Veiga Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds Eur. J. Pharm. Sci. 15 2002 79 88
4. R. Ficarra, P. Ficarra, M.R. Di Bella, D. Raneri, S. Tommasini, M.L. Calabrò, A. Villari, and S. Coppolino Study of the inclusion complex of atenolol with β-cyclodextrin J. Pharm. Biomed. Anal. 23 2000 231 236
5. M.A. Hassan, M.S. Suleiman, and N.M. Najib Improvement of the in-vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin Int. J. Pharm. 58 1990 19 24
6. T. Higuchi, and K.A. Connors Phase solubility technique Adv. Anal. Chem. Instrum. 4 1965 117 212
7. F. Hirayama, and K. Uekama Cyclodextrin-based controlled drug release system Adv. Drug Deliv. Rev. 36 1999 125 141
8. S.Y. Lin, and J.C. Yang Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics Pharm. Weekbl. [Sci]. 8 1986 223 228
9. T. Loftsson, and M. Brewster Pharmaceutical application of cyclodextrins. I. Drug solubilization and stabilization J. Pharm. Sci. 85 1996 1017 1025
10. J.R. Moyano, M.J. Arias-Blanco, J.M. Ginés, and F. Giordano Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complex Int. J. Pharm. 148 1997 211 217
11. P. Montassier, D. Duchêne, and M.C. Poelman Inclusion complexes of tretinoin with cyclodextrins Int. J. Pharm. 153 1997 199 209
12. K. Okimoto, R.A. Rajewski, K. Uekama, J.A. Jona, and V.J. Stella The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins Pharm. Res. 13 1996 256 264
13. F. Veiga, C. Fernandes, and P. Maincent Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system Drug Dev. Ind. Pharm. 27 2001 523 532
14. K.J. Waleczek, H.M. Cabral Marques, B. Hempel, and P.C. Schmidt Phase solubility studies of pure (-)-α-bisabolol and camomile essential oil with β-cyclodextrin Eur. J. Pharmaceut. Biopharmaceut. 55 2003 247 251
15. J.W. Wong, and K.H. Yuen Improved oral bioavailability of artemisinin through inclusion complexation with β- and γ-cyclodextrin Int. J. Pharm. 227 2001 177 185